D.E. Shaw & Co’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-81,383
| Closed | -$1.1M | – | 3420 |
|
|
2025
Q1 | $1.1M | Sell |
81,383
-360,687
| -82% | -$4.86M | ﹤0.01% | 2133 |
|
|
2024
Q4 | $8.47M | Buy |
442,070
+304,003
| +220% | +$5.83M | 0.01% | 1068 |
|
|
2024
Q3 | $3.14M | Buy |
+138,067
| New | +$3.14M | ﹤0.01% | 1557 |
|
|
2023
Q1 | – | Sell |
-338,167
| Closed | -$9.88M | – | 3605 |
|
|
2022
Q4 | $9.88M | Sell |
338,167
-290,108
| -46% | -$8.47M | 0.01% | 974 |
|
|
2022
Q3 | $12.9M | Sell |
628,275
-130,853
| -17% | -$2.68M | 0.02% | 774 |
|
|
2022
Q2 | $8.78M | Sell |
759,128
-23,967
| -3% | -$277K | 0.01% | 1077 |
|
|
2022
Q1 | $14.5M | Buy |
783,095
+18,482
| +2% | +$342K | 0.01% | 877 |
|
|
2021
Q4 | $15.1M | Buy |
764,613
+44,083
| +6% | +$871K | 0.01% | 855 |
|
|
2021
Q3 | $11.9M | Buy |
720,530
+157
| +0% | +$2.58K | 0.01% | 940 |
|
|
2021
Q2 | $13.2M | Buy |
720,373
+531,861
| +282% | +$9.73M | 0.01% | 913 |
|
|
2021
Q1 | $3.15M | Buy |
+188,512
| New | +$3.15M | ﹤0.01% | 1587 |
|
|
2019
Q4 | – | Sell |
-1,127
| Closed | -$12K | – | 2831 |
|
|
2019
Q3 | $12K | Sell |
1,127
-1,769
| -61% | -$18.8K | ﹤0.01% | 2516 |
|
|
2019
Q2 | $89K | Sell |
2,896
-2,814
| -49% | -$86.5K | ﹤0.01% | 2495 |
|
|
2019
Q1 | $239K | Buy |
5,710
+1,770
| +45% | +$74.1K | ﹤0.01% | 2333 |
|
|
2018
Q4 | $179K | Buy |
+3,940
| New | +$179K | ﹤0.01% | 2398 |
|